Business Services Industry

Ann Arbor, Mich., Research Firm Makes Its Market Debut.(Knight Ridder/Tribune Business News)

Knight Ridder/Tribune Business News, August, 2000 by Bennett, Jeff

Aug. 11--An Ann Arbor research company -- trying to develop a drug to raise the level of "good cholesterol" in humans -- went public Thursday when shares of the company's stock began trading on the Nasdaq exchange.

Shares of Esperion Therapeutics Inc. rose 31 percent to close at $11.75 Thursday, up from its $9 initial public offering price. The shares were the second highest traded on Nasdaq, following Evolve Software Inc. of San Francisco, which doubled from $9 to $18. Evolve connects advertisers with clients.

Esperion raised $54 million by selling 6 million shares. It intends to use the money to develop and commercialize therapies, research and development and for licensing agreement payments, as well as for general purposes.

Roger Newton,...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement